Krystal Biotech, Inc. (BIT:1KRYS)

Italy · Delayed Price · Currency is EUR

224.80

-5.70 (-2.47%)

At close: Feb 11, 2026

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Genetic Medicines	290.52M
Genetic Medicines Growth	473.02%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	290.52M
United States Growth	473.02%